Poised to launch a new drug for SMA, Bio­gen and Io­n­is shares jump on more promis­ing PhI­II da­ta

Shares of Bio­gen $BI­IB and Io­n­is Phar­ma­ceu­ti­cals $IONS both jumped ear­ly Mon­day morn­ing af­ter the two biotech part­ners an­nounced an­oth­er pre­lim­i­nary win in a late …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.